Marconescu Praveena, Graviss Edward A, Musher Daniel M
Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
Scand J Infect Dis. 2012 Aug;44(8):620-2. doi: 10.3109/00365548.2012.669843. Epub 2012 Jun 5.
Treatment failure of methicillin-resistant Staphylococcus aureus (MRSA) remains an important concern. In order to investigate new MRSA treatment modalities, we used standard time-kill assays to determine the in vitro killing rate of 22 strains of MRSA by vancomycin, telavancin, daptomycin, and ceftaroline. Studies were carried out with 7-10-times the minimum bactericidal concentrations of each antibiotic in broth culture for 24 h, with subculture at 4, 8, and 24 h. We found that killing by ceftaroline closely paralleled that of vancomycin. Telavancin killed bacteria significantly more slowly, whereas daptomycin killed significantly more rapidly.
耐甲氧西林金黄色葡萄球菌(MRSA)的治疗失败仍然是一个重要问题。为了研究新的MRSA治疗方法,我们使用标准时间杀菌试验来确定22株MRSA对万古霉素、替拉万星、达托霉素和头孢洛林的体外杀菌率。在肉汤培养中,使用每种抗生素最低杀菌浓度的7至10倍进行研究,持续24小时,并在4小时、8小时和24小时进行传代培养。我们发现,头孢洛林的杀菌情况与万古霉素非常相似。替拉万星杀灭细菌的速度明显更慢,而达托霉素杀灭细菌的速度明显更快。